GP-SMA — 20mg

Technical Overview GP-SMA is a synthetic 31-amino-acid incretin receptor agonist analog bearing a fatty-acid side chain for extended molecular stability. In biochemical research settings, this peptide is frequently investigated for its role in incretin receptor binding and receptor-selectivity studies in cell-culture assays. GP-SMA is synthesized and purified to research-use analytical standards suitable for controlled laboratory investigation. This material is prepared using established synthesis and purification methods, with purity assessed by HPLC to a level suitable for research and assay use. Its lyophilized (freeze-dried) powder in a sealed research vial format supports stable handling, storage, and preparation in controlled scientific environments. Composition • Listed as: GP-SMA • C187H291N45O59 · 4,113.58 g/mol • Appearance: white to off-white lyophilized (freeze-dried) powder in a sealed research vial • Stated purity: ≥99.2% by HPLC Handling and storage • Sealed containers ship at ambient temperature and are stable in transit • For laboratory storage, keep the sealed material cold and protected from light and moisture • Lot expiry and release status are printed on the label and mirrored on the lot record Documentation • Every released lot carries a lot-specific Certificate of Analysis identified by internal lot number • Match the lot number on the label to the lot number on the report to connect the material in hand to its results • Reports are retained online and reachable through the container QR code For Research Use Only. Not a drug, supplement, food, or medical device. Not for human or veterinary use, diagnostic use, or any therapeutic application.